Gene Editing Experiment Halted as Patient Gets Weird Side Effects
Verve Therapeutics has paused the first phase of a human gene-editing drug trial aimed at reducing heart disease due to serious side effects.
Verve Therapeutics has paused the first phase of a human gene-editing drug trial aimed at reducing heart disease due to serious side effects.